Polyneuron Pharmaceuticals

Polyneuron develops a promising new drug class to treat autoimmune disorders of the nervous system with unprecedented efficacy and safety.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Basel, Switzerland
  • Currency CHF
  • Founded November 2014
  • Employees 6
  • Incorporation Type Other
  • Website polyneuron.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free